Non-Invasive Chromosomal Evaluation of Trisomy Study

NCT02201862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-04-30

No results posted yet for this study

Summary

This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.

Conditions

  • Aneuploidy
  • Trisomy 21
  • Trisomy 18
  • Trisomy 13
  • Down Syndrome

Sponsors & Collaborators

  • Cindy Cisneros

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2019-08-01
Completion
2019-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02201862 on ClinicalTrials.gov